V-Bio Partners 2
ActiveSummary
V-Bio Partners 2 has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €30,015 and a net result of -€2,235. Equity has been shrinking by about 8.3% per year since 2021. The computed 12-month bankruptcy probability is 1.0% (low).
Overview
Official details
Source: KBO- Status
- Active since 18-11-2020 Normal situation
- Registered office
- 16 active companies are registered at this address Source: KBO register, as of 3 November 2026.
- Activity
- No activity registered in the KBO
- Establishment unit
- 2.313.119.804 9051 Gent, since 18-11-2020
- Financial year end
- 31 December
- Peppol
- Reachable since 19-11-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 1.0%
- Gross margin
- -€1,571
- ▲ 35.7%
- Loss
- €2,235
- ▼ 27.6%
- Equity
- €30,015
- ▼ 6.9%
- Total assets
- €31,215
- ▼ 7.5%
Score breakdownraises riskNo main activity registeredFounded in 2020lowers riskLiquidity: current ratio 5.18, cash €6,215Equity €30,015 (96.2% of total assets)Show the evidence
Checked score
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 81% of them on solvency, 69% on liquidity, 17% on profitability and 28% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 5 accounts on average 5 days before the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Capital increase of €4,494
- · Gazette deed Incorporation
Key facts about V-Bio Partners 2
- What is the company number of V-Bio Partners 2?
- The company number of V-Bio Partners 2 is 0758.543.661. The VAT number is the same number with BE in front: BE 0758.543.661.
- Where is V-Bio Partners 2 based?
- The registered office is at Pieter van Reysschootlaan 2, 9051 Gent.Company details
- What is the legal form of V-Bio Partners 2?
- The legal form of V-Bio Partners 2 is Private limited company (BV).
- When was V-Bio Partners 2 founded?
- V-Bio Partners 2 was founded on 18-11-2020.
- Is V-Bio Partners 2 still active?
- Yes, V-Bio Partners 2 is an active enterprise in the KBO register.
- What is the turnover of V-Bio Partners 2?
- The annual accounts for financial year 2025 state no turnover. The micro format does not require it.Financials
- Is V-Bio Partners 2 profitable?
- In financial year 2025, V-Bio Partners 2 made a loss of €2,235.
- Where can I find the annual accounts of V-Bio Partners 2?
- V-Bio Partners 2 filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of V-Bio Partners 2 due?
- V-Bio Partners 2 must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.